A Phase Ib/II Study of Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients with Relapsed/Refractory Follicular Lymphoma: Final Analysis and Progression-Free Survival Update

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; pp. 2286 - 2288
Main Authors Diefenbach, Catherine S., Kahl, Brad S., Banerjee, Lalita, McMillan, Andrew K., Miall, Fiona, Briones, Javier, Cordoba, Raul, Burke, John M., Hirata, Jamie, Sharma, Sunil, Musick, Lisa, Abrisqueta Costa, Pau
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-157720